RNASeq profiling of COVID19‐infected patients identified an EIF2AK2 inhibitor as a potent SARS‐CoV‐2 antiviral

• Sidharth Jain,
• Samantha Rego,
• Steven Park,
• Yiran Liu,
• Simone Parn,
• Kush Savsani,
• David S. Perlin,
• Sivanesan Dakshanamurthy

Affiliations

Sidharth Jain

Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington DC District of Columbia 20057 USA

Samantha Rego

Georgetown College Georgetown University Washington DC District of Columbia 20057 USA

Steven Park

Center for Discovery and Innovation Hackensack Meridian Health New Jersey 07110 USA

Yiran Liu

Department of Biochemistry & Molecular Biology Georgetown University Medical Center Washington DC District of Columbia 20057 USA

Simone Parn

College of Arts & Science University of the District of Columbia Washington DC District of Columbia 20008 USA

Kush Savsani

College of Humanities and Sciences Virginia Commonwealth University Richmond Virginia 23284 USA

David S. Perlin

Center for Discovery and Innovation Hackensack Meridian Health New Jersey 07110 USA

Sivanesan Dakshanamurthy

Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington DC District of Columbia 20057 USA